Schonfeld Strategic Advisors LLC
Position in VRDN — Viridian Therapeutics, Inc.\DE
CIK 1665241
NEW YORK, NY
Position in VRDN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,576,741
+$7,810,195 QoQ
Shares Held
793,508
+264.9% QoQ
Ownership
0.700%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#40
of 212 holders
Holding Since
Sep 2021
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. VRDN ranks #4 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
697,586 | $66,096,273 | |
| 2 | AGIO |
Agios Pharmaceuticals, Inc.
|
520,083 | $19,300,280 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
77,272 | $18,620,233 | |
| 4 | VRDN |
Viridian Therapeutics, Inc.\DE
This page
|
793,508 | $14,576,741 | |
| 5 | MBX |
MBX Biosciences, Inc.
|
248,670 | $13,726,584 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
227,330 | $13,721,638 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
147,425 | $12,025,457 | |
| 8 | INSM |
INSMED Inc
|
104,378 | $11,128,782 |
All Filings in VRDN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,576,741 | 793,508 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $6,766,546 | 217,434 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,250,086 | 57,928 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,939,738 | 138,751 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,098,741 | 81,509 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,855,402 | 670,600 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $17,360,934 | 763,118 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,896,246 | 145,753 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,871,867 | 164,013 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,896,855 | 178,919 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,657,287 | 108,037 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $555,900 | 23,367 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $917,194 | 31,400 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,079,297 | 52,623 | Shares | Sole | 2022-11-14 | |
| 2021-12-31 | $425,292 | 21,512 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $723,800 | 44,000 | Shares | Sole | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||